Dupilumab Therapeutic Cheat Sheet
DupilumabAtopic dermatitis (AD) is a common skin condition characterized by pruritus and occurs as a result of factors related to impaired skin barrier and immune response, as well as environmental and infectious agents. Patients with poor control on topical therapy are looking for safe and effective systemic treatments. We continue our series, Therapeutic Cheat Sheet, with a closer look at dupilumab, whic …
Dupilumab
Patient Buzz Series: From itchy, raised tattoos to blue light protection skincare
raised, itchy tattoosThis month’s Patient Buzz includes articles discussing a variety of topics such as itchy, raised tattoos (is this normal?), blue light protection skincare, and other topics uniquely related to the COVID-19 pandemic. Is COVID-19 to blame for eczema flares? Is makeup gone unused in the pandemic still safe to use? Is blue light from extra screen time during the pandemic damaging our skin? What are …
raised, itchy tattoos
Lessons from the Skin Microbiome: Innate Immunity, Skin Disease, and COVID-19
skin microbiomeWhile I was beginning the process of “scrubbing in” to assist in the hemicolectomy case as an intern, I carefully squeezed the anti-septic chlorhexidine-soaked sponge and watched the brown solution drip its way down my forearms. I continued the ritual by cleaning under the fingernails and on every plane of the fingers, hands, and forearms multiple times. After all; “Clean Hands Save Lives,� …
skin microbiome
Easing the Management of Atopic Dermatitis
Atopic DermatitisDr. Friedman, jack of many trades, Professor and Interim Chair of Dermatology at George Washington University provided an excellent overview of ways to achieve victory over atopic dermatitis (AD). This expert discussion took place during the ODAC Inflammatory Diseases Symposium on December 3, 2020. How could we possibly cover atopic dermatitis in 20 minutes? Well, Dr. Friedman skillfully led us …
Atopic Dermatitis
JDD February 2021 Issue Highlights: From Acne and Depression to “Inflammaging”
AcneThe February issue of the Journal of Drugs in Dermatology features an outstanding line-up of articles with topics ranging from acne and depression to "Inflammaging. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Efforts are needed to implement a clinically useful definition of moderate plaque psoriasis in Dermatologists’ Perspectives on Defining Moderate Ps …
Acne
error

Enjoy this blog? Please spread the word :)